Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 3 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 11, 2023 Filed Apr 13, 2023 20:15 UTC |
Buehler KevinDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024206 · doc4.xml · derivative · entry 2 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On April 11, 2022 the Issuer granted RSUs to the Reporting Person in connection with the Reporting Person's service as Chair of the Board. The RSUs vested in full on April 11, 2023. F3 · derivative.expiration_date: On April 11, 2022 the Issuer granted RSUs to the Reporting Person in connection with the Reporting Person's service as Chair of the Board. The RSUs vested in full on April 11, 2023. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:15 UTC |
Buehler KevinDirector
|
Exercise / conversionCommon Stock | 5,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-024206 · doc4.xml · nonDerivative · entry 1 Buehler Kevin · CIK 0001792722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on April 11, 2023 F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 20:00 UTC |
Amoroso MichaelDirector · President and CEO
|
SaleCommon Stock | 46,999 | $0.82 | $38,539.18 |
DisclosureSEC source: 0001209191-23-020716 · doc4.xml · nonDerivative · entry 2 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,738 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 20:00 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 102,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-020716 · doc4.xml · derivative · entry 3 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,009 Underlying: Common Stock · 102,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On March 21, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 21, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 21, 2023 Filed Mar 23, 2023 20:00 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 102,535 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-020716 · doc4.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 21, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 13:19 UTC |
Kelly John AlexanderChief Financial Officer
|
PurchaseCommon Stock | 20,000 | $0.86 | $17,200.00 |
DisclosureSEC source: 0001209191-23-020154 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,614 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.847 to $0.87. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 17:19 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 12,172 | $1.07 | $13,024.04 |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,063 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 22:16 UTC |
List AlanChief Medical Officer
|
SaleCommon Stock | 9,473 | $1.07 | $10,136.11 |
DisclosureSEC source: 0001209191-23-016857 · doc4.xml · nonDerivative · entry 2 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,240 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 17:19 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 27,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,101 Underlying: Common Stock · 27,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 17:19 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 27,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:16 UTC |
List AlanChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 29,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016857 · doc4.xml · derivative · entry 3 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,890 Underlying: Common Stock · 29,453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:16 UTC |
List AlanChief Medical Officer
|
Exercise / conversionCommon Stock | 29,453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016857 · doc4.xml · nonDerivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 15,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016842 · doc4.xml · derivative · entry 4 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,144 Underlying: Common Stock · 15,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
Exercise / conversionCommon Stock | 15,576 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016842 · doc4.xml · nonDerivative · entry 2 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:08 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 51,071 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016835 · doc4.xml · derivative · entry 3 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,114 Underlying: Common Stock · 51,071 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:08 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 51,071 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016835 · doc4.xml · nonDerivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:04 UTC |
Barton ShaneVP & Corporate Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 12,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016824 · doc4.xml · derivative · entry 2 Barton Shane · CIK 0001836297 · VP & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,439 Underlying: Common Stock · 12,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F3 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 22:04 UTC |
Barton ShaneVP & Corporate Controller
|
Exercise / conversionCommon Stock | 12,722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016824 · doc4.xml · nonDerivative · entry 1 Barton Shane · CIK 0001836297 · VP & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| February 28, 2023 Filed Mar 7, 2023 17:19 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantCommon Stock | 2,163 | $0.95 | $2,054.85 |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,677 Read SEC document |
| February 28, 2023 Filed Mar 7, 2023 22:12 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantCommon Stock | 12,157 | $0.95 | $11,549.15 |
DisclosureSEC source: 0001209191-23-016842 · doc4.xml · nonDerivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,914,631 Read SEC document |
| February 28, 2023 Filed Mar 7, 2023 22:08 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantCommon Stock | 11,605 | $0.95 | $11,024.75 |
DisclosureSEC source: 0001209191-23-016835 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,543 Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 16:30 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantRestricted Stock Units · Derivative | 178,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004606 · doc4.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,000 Underlying: Common Stock · 178,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:30 UTC |
SMITH J. JEFFERSONChief Research Officer
|
GrantRestricted Stock Units · Derivative | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004611 · doc4.xml · derivative · entry 1 SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:30 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004610 · doc4.xml · derivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:30 UTC |
Barton ShaneVP & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004609 · doc4.xml · derivative · entry 1 Barton Shane · CIK 0001836297 · VP & Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:30 UTC |
Amoroso MichaelDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004608 · doc4.xml · derivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:30 UTC |
List AlanChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 180,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004607 · doc4.xml · derivative · entry 1 List Alan · CIK 0001858530 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 16:20 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
GrantRestricted Stock Units · Derivative | 165,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055799 · doc4.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,200 Underlying: Common Stock · 165,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 20:11 UTC |
Amoroso MichaelDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 850,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055786 · doc4.xml · derivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 850,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 20:14 UTC |
Kelly John AlexanderChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 324,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055788 · doc4.xml · derivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,500 Underlying: Common Stock · 324,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award represents a retention grant, which vests in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 11:00 UTC |
Amoroso MichaelDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001209191-22-054587 · doc4.xml · derivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2032-10-23 F1 · security: The Reporting Person was granted stock options in accordance with the Reporting Person's employment agreement with the Issuer. F2 · derivative.exercise_date: The option vests as to 25% of the underlying shares on October 15, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:13 UTC |
Amoroso MichaelDirector · President and CEO
|
SaleCommon Stock | 11,006 | $1.32 | $14,527.92 |
DisclosureSEC source: 0001209191-22-053956 · doc4.xml · nonDerivative · entry 2 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,202 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 20:13 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 24,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053956 · doc4.xml · derivative · entry 3 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022. F4 · derivative.expiration_date: On October 15, 2021 the Reporting Person was granted RSUs, which vested on October 15, 2022. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 20:13 UTC |
Amoroso MichaelDirector · President and CEO
|
Exercise / conversionCommon Stock | 24,208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-053956 · doc4.xml · nonDerivative · entry 1 Amoroso Michael · CIK 0001830874 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on October 15, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 20:10 UTC |
Kelly John AlexanderChief Financial Officer
|
PurchaseCommon Stock | 8,200 | $1.23 | $10,086.00 |
DisclosureSEC source: 0001209191-22-051240 · doc4.xml · nonDerivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,938 Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 20:10 UTC |
Kelly John AlexanderChief Financial Officer
|
PurchaseCommon Stock | 37,037 | $1.34 | $49,629.58 |
DisclosureSEC source: 0001209191-22-051240 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,738 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.34 to $1.35. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 12:59 UTC |
Kelly John AlexanderChief Financial Officer
|
PurchaseCommon Stock | 33,784 | $1.50 | $50,676.00 |
DisclosureSEC source: 0001209191-22-039100 · doc4.xml · nonDerivative · entry 1 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,701 Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 16:36 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
SaleCommon Stock | 9,833 | $2.06 | $20,255.98 |
DisclosureSEC source: 0001209191-22-035410 · doc4.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,514 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:42 UTC |
JANTZ DEREKDirector · Chief Scientific Officer
|
SaleCommon Stock | 18,849 | $2.06 | $38,828.94 |
DisclosureSEC source: 0001209191-22-035417 · doc4.xml · nonDerivative · entry 3 JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,055,174 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 9,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035410 · doc4.xml · derivative · entry 5 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,089 Underlying: Common Stock · 9,047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F5 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F5 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035410 · doc4.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,727 Underlying: Common Stock · 22,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F4 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 9,047 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035410 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 16:36 UTC |
Scimeca DarioGeneral Counsel and Secretary
|
Exercise / conversionCommon Stock | 22,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035410 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:42 UTC |
JANTZ DEREKDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 12,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035417 · doc4.xml · derivative · entry 5 JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,391 Underlying: Common Stock · 12,199 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F5 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F5 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:42 UTC |
JANTZ DEREKDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 29,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035417 · doc4.xml · derivative · entry 4 JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,545 Underlying: Common Stock · 29,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F4 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:42 UTC |
JANTZ DEREKDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 12,199 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035417 · doc4.xml · nonDerivative · entry 2 JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,074,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:42 UTC |
JANTZ DEREKDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 29,545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035417 · doc4.xml · nonDerivative · entry 1 JANTZ DEREK · CIK 0001769828 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,061,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:30 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 13,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035405 · doc4.xml · derivative · entry 4 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,270 Underlying: Common Stock · 13,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F4 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:30 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 34,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035405 · doc4.xml · derivative · entry 3 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,091 Underlying: Common Stock · 34,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. F3 · derivative.exercise_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates F3 · derivative.expiration_date: On June 7, 2021 the Reporting person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:30 UTC |
Kelly John AlexanderChief Financial Officer
|
Exercise / conversionCommon Stock | 13,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-035405 · doc4.xml · nonDerivative · entry 2 Kelly John Alexander · CIK 0001590030 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022. F2 · price: Each RSU represents a contingent right to receive one share of the Company's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.